• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Notch 信号促进成熟 T 细胞淋巴瘤的发生。

Notch Signaling Promotes Mature T-Cell Lymphomagenesis.

机构信息

Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan.

Department of Pathology, University of Illinois Chicago, Chicago, Illinois.

出版信息

Cancer Res. 2022 Oct 17;82(20):3763-3773. doi: 10.1158/0008-5472.CAN-22-1215.

DOI:10.1158/0008-5472.CAN-22-1215
PMID:36006995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9588752/
Abstract

UNLABELLED

Peripheral T-cell lymphomas (PTCL) are agressive lymphomas that develop from mature T cells. The most common PTCLs are genetically, molecularly, and clinically diverse and are generally associated with dismal outcomes. While Notch signaling plays a critically important role in both the development of immature T cells and their malignant transformation, its role in PTCL is poorly understood, despite the increasingly appreciated function of Notch in regulating the proliferation and differentiation of mature T cells. Here, we demonstrate that Notch receptors and their Delta-like family ligands (DLL1/DLL4) play a pathogenic role in PTCL. Notch1 activation was observed in common PTCL subtypes, including PTCL-not otherwise specified (NOS). In a large cohort of PTCL-NOS biopsies, Notch1 activation was significantly associated with surrogate markers of proliferation. Complementary genetically engineered mouse models and spontaneous PTCL models were used to functionally examine the role of Notch signaling, and Notch1/Notch2 blockade and pan-Notch blockade using dominant-negative MAML significantly impaired the proliferation of malignant T cells and PTCL progression in these models. Treatment with DLL1/DLL4 blocking antibodies established that Notch signaling is ligand-dependent. Together, these findings reveal a role for ligand-dependent Notch signaling in driving peripheral T-cell lymphomagenesis.

SIGNIFICANCE

This work demonstrates that ligand-dependent Notch activation promotes the growth and proliferation of mature T-cell lymphomas, providing new therapeutic strategies for this group of aggressive lymphomas.

摘要

未注明

外周 T 细胞淋巴瘤(PTCL)是一种来源于成熟 T 细胞的侵袭性淋巴瘤。最常见的 PTCL 在遗传、分子和临床方面具有多样性,通常与预后不良相关。尽管 Notch 信号在不成熟 T 细胞的发育及其恶性转化中起着至关重要的作用,但 Notch 在 PTCL 中的作用仍知之甚少,尽管 Notch 在调节成熟 T 细胞的增殖和分化方面的功能日益受到重视。在这里,我们证明 Notch 受体及其 Delta 样家族配体(DLL1/DLL4)在外周 T 细胞淋巴瘤中发挥致病作用。常见的 PTCL 亚型包括未特指的 PTCL(NOS)中观察到 Notch1 激活。在 PTCL-NOS 活检的大队列中,Notch1 激活与增殖的替代标志物显著相关。互补的基因工程小鼠模型和自发性 PTCL 模型用于功能检查 Notch 信号的作用,Notch1/Notch2 阻断和泛 Notch 阻断使用显性负性 MAML 显著损害这些模型中恶性 T 细胞的增殖和 PTCL 进展。DLL1/DLL4 阻断抗体的治疗表明 Notch 信号是配体依赖性的。总之,这些发现揭示了配体依赖性 Notch 信号在外周 T 细胞淋巴瘤发生中的作用。

意义

这项工作表明,配体依赖性 Notch 激活促进了成熟 T 细胞淋巴瘤的生长和增殖,为这组侵袭性淋巴瘤提供了新的治疗策略。

相似文献

1
Notch Signaling Promotes Mature T-Cell Lymphomagenesis.Notch 信号促进成熟 T 细胞淋巴瘤的发生。
Cancer Res. 2022 Oct 17;82(20):3763-3773. doi: 10.1158/0008-5472.CAN-22-1215.
2
Intraovarian regulation of gonadotropin-dependent folliculogenesis depends on notch receptor signaling pathways not involving Delta-like ligand 4 (Dll4).卵巢内促性腺激素依赖性卵泡发生的调节依赖于不涉及 Delta 样配体 4 (Dll4) 的 Notch 受体信号通路。
Reprod Biol Endocrinol. 2013 May 15;11:43. doi: 10.1186/1477-7827-11-43.
3
Dll1 Can Function as a Ligand of Notch1 and Notch2 in the Thymic Epithelium.Dll1 可作为胸腺上皮细胞中 Notch1 和 Notch2 的配体。
Front Immunol. 2022 Mar 17;13:852427. doi: 10.3389/fimmu.2022.852427. eCollection 2022.
4
Delta-like 1-Expressing Cells at the Gland Base Promote Proliferation of Gastric Antral Stem Cells in Mouse.胃窦部基底 Delta-like 1 表达细胞促进胃贲门干细胞增殖。
Cell Mol Gastroenterol Hepatol. 2022;13(1):275-287. doi: 10.1016/j.jcmgh.2021.08.012. Epub 2021 Aug 23.
5
Notch1 engagement by Delta-like-1 promotes differentiation of B lymphocytes to antibody-secreting cells.Delta样蛋白1与Notch1结合可促进B淋巴细胞分化为抗体分泌细胞。
Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15454-9. doi: 10.1073/pnas.0702891104. Epub 2007 Sep 18.
6
CD28 Signaling Drives Notch Ligand Expression on CD4 T Cells.CD28 信号驱动 CD4 T 细胞上的 Notch 配体表达。
Front Immunol. 2020 May 7;11:735. doi: 10.3389/fimmu.2020.00735. eCollection 2020.
7
DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.DLL4 调节 NOTCH 信号通路并促进 NOD/SCID 小鼠 T 急性淋巴细胞白血病细胞的生长。
Carcinogenesis. 2015 Jan;36(1):115-21. doi: 10.1093/carcin/bgu223. Epub 2014 Oct 29.
8
No evidence for a functional role of bi-directional Notch signaling during angiogenesis.在血管生成过程中,双向 Notch 信号传导没有功能作用的证据。
PLoS One. 2012;7(12):e53074. doi: 10.1371/journal.pone.0053074. Epub 2012 Dec 28.
9
Expression of Notch receptors and ligands on immature and mature T cells.Notch 受体及其配体在未成熟和成熟 T 细胞上的表达。
Biochem Biophys Res Commun. 2012 Feb 24;418(4):799-805. doi: 10.1016/j.bbrc.2012.01.106. Epub 2012 Jan 28.
10
Therapeutic antibody targeting of individual Notch receptors.针对单个 Notch 受体的治疗性抗体。
Nature. 2010 Apr 15;464(7291):1052-7. doi: 10.1038/nature08878.

引用本文的文献

1
Notch pathway inhibition with crenigacestat (LY3039478) in a phase I first-in-human clinical trial for patients with relapsed or refractory non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia.在一项针对复发或难治性非霍奇金淋巴瘤和B细胞慢性淋巴细胞白血病患者的I期首次人体临床试验中,使用crenigacestat(LY3039478)抑制Notch信号通路。
Ther Adv Drug Saf. 2025 Jul 31;16:20420986241311461. doi: 10.1177/20420986241311461. eCollection 2025.
2
Molecular heterogeneity of CD30 peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre study.具有预后意义和治疗意义的CD30外周T细胞淋巴瘤的分子异质性:一项回顾性多中心研究
EBioMedicine. 2025 May;115:105693. doi: 10.1016/j.ebiom.2025.105693. Epub 2025 Apr 10.
3

本文引用的文献

1
NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer.NOTCH 和 EZH2 协同作用抑制乳腺癌中 PTEN 的表达。
Commun Biol. 2021 Mar 9;4(1):312. doi: 10.1038/s42003-021-01825-8.
2
Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target.全外显子组测序揭示间变大细胞淋巴瘤中的 NOTCH1 突变,并指出 Notch 既是关键途径,也是潜在的治疗靶点。
Haematologica. 2021 Jun 1;106(6):1693-1704. doi: 10.3324/haematol.2019.238766.
3
Peripheral T cell lymphomas: from the bench to the clinic.
Bioinformatics identification of a T-cell-related signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma.生物信息学鉴定 T 细胞相关特征预测肝细胞癌预后和药物敏感性
IET Syst Biol. 2023 Dec;17(6):366-377. doi: 10.1049/syb2.12082. Epub 2023 Nov 7.
4
Regulation of immune cell development, differentiation and function by stromal Notch ligands.基质 Notch 配体对免疫细胞发育、分化和功能的调节。
Curr Opin Cell Biol. 2023 Dec;85:102256. doi: 10.1016/j.ceb.2023.102256. Epub 2023 Oct 6.
5
SOHO State of the Art Updates and Next Questions | New Pathways and New Targets in PTCL: Staying on Target.SOHO 最新进展与未来展望 | 探讨新途径与新靶点,以实现 PTCL 精准治疗:稳扎稳打。
Clin Lymphoma Myeloma Leuk. 2023 Aug;23(8):561-574. doi: 10.1016/j.clml.2023.04.007. Epub 2023 Apr 19.
6
PTCL, NOS: An update on classification, risk-stratification, and treatment.外周T细胞淋巴瘤,非特指型:分类、风险分层及治疗的最新进展
Front Oncol. 2023 Feb 9;13:1101441. doi: 10.3389/fonc.2023.1101441. eCollection 2023.
7
Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma.外周 T 细胞和自然杀伤/T 细胞淋巴瘤新型治疗药物的新兴预测性生物标志物。
Front Immunol. 2023 Jan 26;14:1068662. doi: 10.3389/fimmu.2023.1068662. eCollection 2023.
外周 T 细胞淋巴瘤:从基础到临床。
Nat Rev Cancer. 2020 Jun;20(6):323-342. doi: 10.1038/s41568-020-0247-0. Epub 2020 Apr 6.
4
Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas.靶向异常 EZH1 和 EZH2 活性以调节恶性淋巴瘤中的异常组蛋白甲基化和转录网络。
Cell Rep. 2019 Nov 19;29(8):2321-2337.e7. doi: 10.1016/j.celrep.2019.10.083.
5
Notch signalling in T cell homeostasis and differentiation.Notch 信号通路在 T 细胞稳态和分化中的作用。
Open Biol. 2019 Nov 29;9(11):190187. doi: 10.1098/rsob.190187. Epub 2019 Nov 6.
6
Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.通过全面的遗传分析揭示未特指的外周 T 细胞淋巴瘤的分子异质性。
Leukemia. 2019 Dec;33(12):2867-2883. doi: 10.1038/s41375-019-0473-1. Epub 2019 May 15.
7
SWI/SNF chromatin remodeling controls Notch-responsive enhancer accessibility.SWI/SNF 染色质重塑控制 Notch 反应性增强子可及性。
EMBO Rep. 2019 May;20(5). doi: 10.15252/embr.201846944. Epub 2019 Mar 26.
8
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.外周 T 细胞淋巴瘤分子亚群中致癌途径的遗传驱动因素。
Blood. 2019 Apr 11;133(15):1664-1676. doi: 10.1182/blood-2018-09-872549. Epub 2019 Feb 19.
9
Notch ligand Dll1 mediates cross-talk between mammary stem cells and the macrophageal niche.Notch 配体 Dll1 介导乳腺干细胞与巨噬细胞生态位之间的串扰。
Science. 2018 Jun 29;360(6396). doi: 10.1126/science.aan4153. Epub 2018 May 17.
10
PI5P4Kγ functions in DTX1-mediated Notch signaling.PI5P4Kγ 在 DTX1 介导的 Notch 信号通路中发挥作用。
Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):E1983-E1990. doi: 10.1073/pnas.1712142115. Epub 2018 Feb 12.